1.The treatment of the leg deep vein thrombosis
Suvd S ; Gundegmaa Ts ; Baasanjav N ; Erdenebayar A
Mongolian Medical Sciences 2018;185(3):147-151
Thrombosis is a term for a blood clot occurring inside a blood vessel. R. Virchow postulated that
abnormalities in blood flow, hypercoagulability of the blood, and injury to the vessel wall are causally
related to thrombus formation. Many of the risk factors for deep vein thrombosis aretrauma for 9.3-
18.8%, birth for 16-17.3%, surgery for 14.3-30.3%, infection disease for 9.7-15.9%, cancer for 3.5%,
heart disease for 4.6% and 6.9-11.8% of deep vein thrombosis is an indistinct cause. Pain, swelling,
warmth, edema and redness in the affected leg are common symptoms.The diagnosis of deep vein
thrombosis of the leg can be difficult with clinical findings and history being unreliable. The National
Institute of Health and Care Excellence has evidence based recommendations on the prevention
and management of a wide range of health conditions. Here: incorporation of a clinical predication
score, D-dimer, and venous duplex ultrasound. The D-dimer blood test measures degraded fibrinogen, which is raised in patients with a clot. However, it cannot confirm deep vein thrombosis, as
D-dimer can be raised in other conditions including malignancy, infection, pregnancy, post-surgery,
inflammation, trauma, disseminated intravascular coagulopathy, and renal impairment. There are
two types venous ultrasound as the first line investigation for suspected deep vein thrombosis.
The aim of treatment for deep vein thrombosis are:
• The prevention of a thrombus progress
• Decrease the risk of the pulmonary embolism
• The reduction of the thrombus expansion or resolution.
• The prevention of the post thrombotic symptoms
• Decrease the mortality of vein thrombosis
Guidelines from NICE and ACCP recommended direct oral anticoagulants as first line treatment for
deep vein thrombosis. Direct oral anticoagulants include direct factor Xa inhibitors apixaban, rivaroxaban, and edoxaban, and a direct thrombin inhibitor dabigatron
2.ADULT ORTHODONTICS WITH DAHL TECHNIQUE FOR BETTERFUNCTION AND AESTHETICS
Bilgee J ; Gantsetseg L ; Enkhjargal N ; Khorolbayar Sh ; Temuulen B ; Orkhon B ; Urjinlkham J
Innovation 2018;12(4):40-44
BACKGROUND. The Dahl Concept refers to the relative axial tooth movement that is observed when a localized restorations are placed in supra-occlusion in dental hard tissue worn anterior area and posterior full arch occlusal contacts re-establishes over a period of time irrespective of age and gender. The literature reports that the objectives of the Dahl concept are achieved in the majority of cases (94%-100%). Some minor and transient adverse events, such as initial difficulty with mastication could develop. If dental arch is crowded and some of the teeth are pushed away, they tends to be pushed more even they were visually aligned by a heavy preparation under the ceramic restorations such as crowns and veneers. To avoid these costly and teeth-harmful treatment options for patients with anterior crowding and who wants straighter and beautiful looking teeth, we use a conservative approach of Align+Bleach+Bonding technique.
MATEREALS AND METHOD. For tooth alignment we used Inman Aligner, Clear Aligner and Clear Smile Braces (fixed ceramic braces with super elastic Ni-Ti wires) or their combination. After short orthodontics a Dahl concept was applied to improve patients’ functional occlusion and anterior guidance. A “free-hand” and “no-any-drill” composite restoration technique was used to restore worn anterior teeth. For proper orthodontic diagnosis, assessment and treatment planning Spacewise analysis and Digital Caliper measurement were performed using models, their digital scans and intra/extraoral photos. We use Inman Orthodontic Lab in Florida for Inman Aligner fabrication and IAS Laboratory in London for Clear smile braces set up. Clear aligners (Scheu Dental, Germany) are planned and fabricated at the Digital Dental Office’s Clear Aligner certified laboratory. All treatments are start only after thorough diagnostic analysis, case discussion and acceptance from technical experts and orthodontists from UK, USA and Germany and acceptance of planned results from the patients. A course of home bleaching was then performed followed by resin bonding of anterior teeth edges to stabilize anterior guidance.
RESULTS. More than 200 cases of upper and lower anterior crowding have been treated in comparably short period of time. From those we are introducing 3 different cases which were treated using above mentioned three appliances as an example. Average orthodontic treatment lasted 8-16 weeks depending on degree of crowding and type of appliances used. The arch crowding were less than 4 mm in all of them. No any teeth were extracted. After orthodontic treatment patients had double retentions (fixed+clear retainers). Dahl concept was performed in patients with anterior attrition and few patients experienced minor difficulty with chewing for their first week only. To control results of molar extrusion we measured space between occlusal surfaces of opposing molars in the SAM 3 articulator positioned in the centric relation.
CONCLUSION. In order to get a long term proper stability of dento-facial function with a bonus of beautiful smile the concept of keeping own teeth and its structure became essential in cosmetic and restorative dentistry. The good thing of Dahl technique is its simplicity if it is done properly and its cost effectiveness. And as it was described the edge bonding itself could be a permanent retainer which prevents a future relapse in ortho-aligned teeth. Moreover patients were highly satisfied due to fast alignment, opportunity of keeping their teeth untouched and getting aesthetically pleasant result with a stable function.
3.Results of determination of salidroside content in roots and rhizomes of cultivated and natural Rhodiola rosea L
Khishigjargal B ; Lkhaasuren R ; Batdorj D ; Suvdaa T ; Gantogtokh G ; Orkhon N ; Tsetsegmaa S ; Khurelbaatar L
Mongolian Medical Sciences 2021;195(1):51-55
Introduction:
Rhodiola rosea L. (R.rosea) is a popular plant in traditional medicine of the Nordic countries, Eastern
Europe, and Asia. R.rosea plants are successfully cultivated in Mongolia. The Botanical Garden of
Medicinal Plants under the “Monos” Group started to cultivate R. rosea since May 2015.
Objective:
The aim of this research was to study the salidroside contents of R.rosea collected from Zavkhan
and Khuvsgul province, Mongolia, and cultivated in the Botanical Garden of Medicinal Plants, Drug
research Institute, Monos group.
Material and Methods:
The underground parts of wild roseroot plants were collected from April to May 2020 from Jargalant
soum, Khuvsgul province, and Nomrog soum, Zavkhan province, 3-years and 4-years-old cultivated
R.rosea gathered from the Botanical Garden of Medicinal Plants in April 2020. For comparison,
4-year-old Rhodiola grenulata (R. grenulata) was ordered from Shanxi Zhendong Genuine Medicinal
Materials Development Co., Ltd, China, and used for the study. The quantity of the salidroside
constituents of the underground parts were compared and the sourcing of roseroot raw material was
evaluated. Chemical analysis of roots and rhizome of R. Rosea namely the appearance, identification,
moisture, organic impurities, mineral impurities, residue on ignition, water-soluble extractives, fresh
weight of roots, and salidroside content were determined according to the National Pharmacopoeia of
Mongolia (NPhM) 2011. Microbiological analysis was performed in accordance with the requirements
of grade 3b specified in Annex 1 of the Order No. A / 219 of the Minister of Health dated May 30,
2017 to determine the degree of microbiological purity in medicinal products of roots and rhizome
raw materials.
Result:
The content of salidroside, the main biologically active substance of R.rosea plant, was 1.57% in
samples collected from Zavkhan province, 1.45% in samples collected from Khuvsgul province, 1.7%
in samples grown in China and 0.25% for 3-years-old samples and 1.89% for 4-years-old samples grown in the Botanical Garden of Medicinal Plants, Monos group, Mongolia. In addition, these raw
materials meet the general requirements for plant raw materials and microbiological parameters.
Conclusion
Samples of underground parts of R.rosea cultivated for 4 years in the Botanical Garden of Medicinal
Plants have the highest content (1.89%) of the salidrosde. Therefore, it is suggested that the roots
and rhizomes of R.rosea planted in the future can be standardized and used as a raw materials for
medicines.
4.Determination of inuline contents in heat and cold processed Helianthus Tuberosus L.
Ganchimeg G ; Batdorj D ; Lkhaasuren R ; Odchimeg B ; Battulga B ; Orkhon N ; Ulziimunkh B ; Bayanmunkh A ; Tsetsegmaa S ; Lkhagva L ; Khurelbaatar L
Mongolian Pharmacy and Pharmacology 2021;19(2):38-42
Introduction:
Helianthus tuberosus L. is main source of inuline in pharmaceutical and food industry. Pharmacological studies of the plant have showed some important therapeutic properties such as anti-diabetic, anti-osteoporosis, anti-cancer and strengthening cardiovascular system, immune system.
Material and method:
Helianthus tuberosus L., which has been cultivated in Botanical Garden of Medicinal Plants of Drug Research Institute, Monos Group, was used as a research raw material. The aerial and below ground parts of the plants were harvested in September 2020. The content of inulin, the main active ingredient in the plant, was determined by spectrophotometry. Raw materials of the plant were processed in several ways and prepared for further use as a pharmaceutical raw material.
Result:
Inulin content in Sample 1 was 34.5 ± 0.76%, Sample 2 was 70.31 ± 1.25%, Sample 3 was
78.43 ± 0.44% and Sample 4 was 75.36 ± 1.42%. The inulin content and yield were the highest in samples prepared by heat and cold cutting methods.
Conclusion
According to the results of appearance, yield, inulin content and moisture contents during the different processings of plant materials, it can be considered that the most suitable method for preparing Helianthus tuberosus L. as a pharmaceutical raw material is the cutting followed by freeze-drying.